Connector for packaging containing medical fluids and packaging for medical fluids

Details for Australian Patent Application No. 2003208752 (hide)

Owner Fresenius Kabi Deutschland GmbH

Inventors Brandenburger, Torsten; Rahimu, Ismael

Agent Davies Collison Cave

Pub. Number AU-B-2003208752

PCT Number PCT/EP03/01847

PCT Pub. Number WO2003/099191

Priority 102 23 560.0 27.05.02 DE

Filing date 24 February 2003

Wipo publication date 12 December 2003

Acceptance publication date 10 July 2008

International Classifications

A61J 1/05 (2006.01) Containers specially adapted for medical or pharmaceutical purposes - for collecting, storing or administering blood, plasma or medical fluids

A61J 1/10 (2006.01) Containers specially adapted for medical or pharmaceutical purposes - Bag-type containers

A61J 1/20 (2006.01) Containers specially adapted for medical or pharmaceutical purposes

A61M 25/18 (2006.01) Catheters

B65D 33/38 (2006.01) Details of, or accessories for, sacks or bags

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 102 23 560.0 27.05.02 DE

5 February 2004 Application Open to Public Inspection

  Published as AU-B-2003208752

10 July 2008 Application Accepted

  Published as AU-B-2003208752

31 July 2008 Corrigenda

  Applications Accepted - Name Index Under the Name Fresenius Kabi Deutschland GmbH, Application No. 2003208752, under INID (72) correct the name of the co-inventor if known to be such to Rahimy, Ismael

6 November 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003208753-Isotropic cleansing composition with benefit agent particles

2003208751-METHODS FOR DETERMINING THE INFLUENCE OF HUMAN PLASMA OR SERUM PROTEIN BINDING ON ANTIRETROVIRAL ACTIVITY